Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Tuberous Sclerosis × ganaxolone × Clear all

Phase

Phase 3 2 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Tuberous Sclerosis 1

Interventions

Sirolimus 6 Everolimus 5 ganaxolone 1 dactolisib 1 Vigabatrin 1 Sertraline 1 Selective Serotonin Reuptake Inhibitors 1 Propranolol 1 Aspirin 1 Anticonvulsants 1 2-chloro-4-(1-(4-fluorophenyl)-2,5-dimethyl-1H-imidazol-4-ylethynyl)pyridine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04285346 2023-04-04

TSC

Marinus Pharmaceuticals

Phase 2 Completed

23 enrolled 9 charts

Tuberous Sclerosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡